Endoscopic studies in patients taking aspirin or non-steroidal, anti-inflammatory drugs (NSAIDs) suggest a point prevalence of gastric or duodenal ulceration in excess of 20%. [1] [2] [3] [4] [5] [6] [7] [8] This study was prompted by the observation that the number of ulcers detected endoscopically in patients taking NSAIDsl-8 was disproportionately high in relation to the three to fourfold magnification of the risk of clinically important end points which epidemiological studies identify as being associated with the use of NSAIDs.9 10 This study suggests that lesions diagnosed endoscopically as ulcers in NSAID patients are superficial and similar to erosions and may, therefore, have a relatively low probability of progression to clinically important end points such as haematemesis and melaena. While deeper and potentially life threatening ulcers must start as superficial ones, the problem is to identify at endoscopy those which will do so and to define the risk factors and mechanisms by which these are selected. Until this is achieved, uncertainties about the predictive value of ulcers discovered at endoscopy in patients taking NSAIDs raise some doubts about the clinical and prognostic importance of prophylaxis studies which use them as end points. Similarly, confusion in the categorising of NSAID associated gastric erosions may compromise their importance in predicting future ulceration. '8 Our study was made possible by the use of video endoscopy, since this allows recording of high quality images and subsequent viewing by a panel under controlled blinded conditions. Our panel had been trained in a wide range of units within British gastroenterology. The methodology used is suitable for extension to a larger number of gastroenterologists (for example, by presentation at a national meeting), when evaluation of a wider range of lesions, and subgroup analysis by experience could be investigated. When more valid definitions of gastroduodenal lesions, particularly in patients taking NSAIDs, are agreed video endoscopy could also be used as a vehicle of audit and training to ensure the greater accuracy and uniformity of diagnosis that will be required before the importance of a 'NSAID-associated ulcer' discovered at endoscopy can be assessed.
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